Quantcast
Last updated on April 17, 2014 at 15:37 EDT

Latest Allergic Rhinitis Stories

2012-09-17 22:21:19

OXFORD, England, September 18, 2012 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the appointment of Stewart Sharpe to the newly-created position of Vice President, Commercial Operations. Mr Sharpe, who has extensive experience of leading multinational product launches, will lead Circassia's preparations to commercialise its lead allergy programme. Circassia plans to begin phase III testing of its lead ToleroMune(R)...

2012-09-07 10:22:22

CHICAGO, Sept. 7, 2012 /PRNewswire/ -- Itchy, runny nose, sneezing, nasal congestion. What a way to end the summer! With an off-the-charts Chicago mold count in recent weeks, your misery may actually be mold allergies, not a summer cold. Allergic rhinitis (hay fever) and asthma sufferers are experiencing nasal congestion and hay fever symptoms like never before as the Windy City blows microscopic mold spores in everyone's path. These days, the allergy index is all about mold count, not pollen...

2012-08-17 14:20:32

CHICAGO, Aug. 17, 2012 /PRNewswire/ -- Do you suffer from hay fever or allergies? Are they one in the same? For those with persistently stuffy, itchy noses, post-nasal drip, and constant sneezing there may be a bigger question. How do I get relief? Chicago allergy expert, Dr. Brian Rotskoff, knows that's the question patients really want answered. Managing the symptoms of hay fever (allergic rhinitis) and nasal congestion, and helping those who suffer from adult sleep apnea, childhood...

2012-04-11 02:25:00

HORSHAM, Pa., April 11, 2012 /PRNewswire/ -- Teva Respiratory and the Asthma and Allergy Foundation of America (AAFA) announced today the launch of a national awareness campaign - Ditch the Drip, Get Serious about Nasal Allergies - aimed at raising awareness of the seriousness of seasonal and year-round allergies and the need for people living with nasal allergies to adequately prepare for their peak allergy seasons. The program features two-time Olympic volleyball gold medalist and seasonal...

2012-03-14 04:00:00

DUBAI, UAE, March 14, 2012 /PRNewswire/ -- - United Arab Emirates is the First Country in the Middle East to Introduce Omnaris(R) to Region's Allergy Sufferers - Nycomed, a Takeda company, today announced that Omnaris(R) (ciclesonide) Nasal Spray is now available in the United Arab Emirates for the treatment of allergic rhinitis, also known as nasal allergies and hay fever, in adults and adolescents over the age of 12. Omnaris(R) Nasal Spray is a long-lasting...

2011-10-18 06:22:00

GREENWOOD VILLAGE, Colo., Oct. 18, 2011 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NASDAQ:AMPE) ("Ampio" or the "Company"), a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs"), today announced that it has demonstrated in an IRB approved, randomized, placebo controlled, double-blinded proof of concept study, that low dose intranasal danazol has an impact on allergic rhinitis, a clinical condition in which increases in vascular...

2011-05-10 08:07:00

HORSHAM, Pa., May 10, 2011 /PRNewswire/ -- Teva Respiratory today announced results from the recently completed Nasal Allergy Survey Assessing Limitations (NASL) 2010, which found patients with allergic rhinitis (AR) who had nasal symptoms were more likely to experience sleep disturbances, including difficulty getting to sleep and/or waking up during the night. Lack of a good night's sleep can significantly impact a person's quality of life. For people living with nasal allergies in the...

2011-04-27 07:00:00

ST. PAUL, Minn., April 27, 2011 /PRNewswire/ -- Patients with asthma or allergic rhinitis (nasal allergies), initially prescribed montelukast (Singulair®) instead of typical first-line therapy have low rates of persistence on montelukast and may ultimately discontinue therapy altogether, according to a new study presented at the Academy of Managed Care Pharmacy's 23rd Annual Meeting in Minneapolis, Minn. The study will be presented by Prime Therapeutics (Prime), a thought...

2011-03-21 16:47:00

SAN FRANCISCO, March 21, 2011 /PRNewswire/ -- Results from a recent pivotal allergic rhinitis (AR) satisfaction survey assessing patient and healthcare provider perspectives on AR reveal that symptoms like nasal congestion and post-nasal drip continue to impact patients' daily activities. Findings from the Nasal Allergy Survey Assessing Limitations (NASL) 2010, released today by Teva Respiratory at the American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting, held in San...

2011-03-21 11:45:00

SAN FRANCISCO, March 21, 2011 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) agonists and antagonists for the treatment of cancer, respiratory and autoimmune diseases, announced today the presentation of positive clinical results from its randomized, placebo-controlled clinical trial evaluating VTX-1463 for the treatment of allergic rhinitis. The results demonstrated statistically significant...